23-10-30 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-08-03 GSK Nigeria calls an end to its business, to return cash RE
23-08-03 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
23-08-03 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
23-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-10-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
22-07-29 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
22-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
22-01-31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
21-10-25 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
21-07-29 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 2011-07-31
General Counsel - 2017-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
+0.11%+1.71%+63.52%+117.61% 1,056B
+0.27%+0.92%+51.33%+73.35% 655B
+0.73%+0.68%+20.70%+74.90% 471B
-1.36%-2.58%+40.20%+42.33% 342B
+1.34%+4.53%+23.37%+29.55% 277B
-0.48%-0.54%+13.56%+13.50% 257B
+0.85%+6.35%+53.17%+54.39% 226B
+0.85%+1.10%+35.78%+101.82% 189B
-0.30%-2.98%-27.62%-61.28% 170B
Average +0.12%+0.97%+30.45%+49.57% 404.77B
Weighted average by Cap. -0.05%+1.04%+40.70%+69.94%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock